ScholarIQanswers from OpenAlex & ORCID
Scott M. Schuetze
ResearcherPublications, citations & collaboration network
Scott M. Schuetze is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Scott M. Schuetze have?
ScholarIQindexed works
Scott M. Schuetze has 277 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Scott M. Schuetze have?
ScholarIQcitation count
Scott M. Schuetze has 20,625 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Scott M. Schuetze?
ScholarIQh-index
Scott M. Schuetze has an h-index of 60 in OpenAlex.
What is the i10-index of Scott M. Schuetze?
ScholarIQi10-index
Scott M. Schuetze has an i10-index of 133 in OpenAlex.
What is the ORCID of Scott M. Schuetze?
ScholarIQorcid
The ORCID for Scott M. Schuetze is on the source record.
What is the OpenAlex record for Scott M. Schuetze?
ScholarIQopenalex
The OpenAlex for Scott M. Schuetze is on the source record.
What are the most-cited papers on Scott M. Schuetze?
ScholarIQmost cited works
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
George D. Demetri, Margaret von Mehren, Cristina R. Antonescu, Ronald P. DeMatteo, Kristen N. Ganjoo, Robert G. Maki, Peter W. T. Pisters, Chandrajit P. Raut, Richard F. Riedel, Scott M. Schuetze, Hema Sundar, Jonathan C. Trent, Jeffrey D. Wayne
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, John M. Kane, Mark Agulnik, Marilyn M. Bui, Janai R. Carr, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Ricardo González, Ashley M. Holder, Jade Homsi, Vicki L. Keedy, Ciara M. Kelly, Edward Kim, David A. Liebner, Martin D. McCarter, Sean V. McGarry, Nathan W. Mesko, Christian F. Meyer, Alberto S. Pappo, Amanda Parkes, Ivy A. Petersen, Seth M. Pollack, Matthew M. Poppe, Richard F. Riedel, Scott M. Schuetze, Jacob E. Shabason, Jason K. Sicklick, Matthew B. Spraker, Melissa N. Zimel, Lisa E. Hang, Hema Sundar, Mary Anne Bergman
Integrative clinical genomics of metastatic cancer
Dan R. Robinson, Yi-Mi Wu, Robert J. Lonigro, Pankaj Vats, Erin F. Cobain, Jessica N. Everett, Xuhong Cao, Erica Rabban, Chandan Kumar‐Sinha, Victoria M. Raymond, Scott M. Schuetze, Ajjai Alva, Javed Siddiqui, Rashmi Chugh, Francis P. Worden, Mark M. Zalupski, Jeffrey W. Innis, Rajen Mody, Scott A. Tomlins, David R. Lucas, Laurence H. Baker, Nithya Ramnath, Ann F. Schott, Daniel F. Hayes, Joseph Vijai, Kenneth Offit, Elena M. Stoffel, J. Scott Roberts, David C. Smith, Lakshmi P. Kunju, Moshe Talpaz, Marcin Cieślik, Arul M. Chinnaiyan
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
George D. Demetri, Margaret von Mehren, Robin L. Jones, Martee L. Hensley, Scott M. Schuetze, Arthur P. Staddon, Mohammed Milhem, A. Elias, Kristen N. Ganjoo, Hussein A. Tawbi, Brian Andrew Van Tine, Alexander I. Spira, Andrew Dean, Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, Trilok Parekh, Robert G. Maki, Shreyaskumar Patel